Header

Skip to main content

Slider

Home Edu Highlight, Disease Overview, Symptoms, Expert Insights
amyloidosis, parkinsons, alzheimers, systemic amyloidosis

Expert Insights: The Systemic Amyloidoses vs. Parkinson’s vs. Alzheimer’s

November 09, 2023

Expert Insights: The Systemic Amyloidoses vs. Parkinson’s vs. Alzheimer’s

Current medical education on amyloid diseases is 25 years old and materially outdated, punctuated by rapid advancement in the last five years. Hear from renowned Dr. Jeff Kelly from Scripps Research, developer of ATTR drug Tafamidis, about the current biology and how amyloid diseases such as the Systemic Amyloidoses (ATTR and AL), Parkinson’s and Alzheimer’s are today believed to be more similar than different.

This website uses cookies

This site uses cookies to provide more personalized content, social media features, and ads, and to analyze our traffic. We might share information about your use of our site with our social media, advertising, and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will never sell your information or share it with unaffiliated entities.